1. Home
  2. IMCR vs GEL Comparison

IMCR vs GEL Comparison

Compare IMCR & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCR
  • GEL
  • Stock Information
  • Founded
  • IMCR 2008
  • GEL 1996
  • Country
  • IMCR United Kingdom
  • GEL United States
  • Employees
  • IMCR N/A
  • GEL N/A
  • Industry
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • GEL Oil Refining/Marketing
  • Sector
  • IMCR Health Care
  • GEL Energy
  • Exchange
  • IMCR Nasdaq
  • GEL Nasdaq
  • Market Cap
  • IMCR 1.4B
  • GEL 1.6B
  • IPO Year
  • IMCR 2021
  • GEL 1996
  • Fundamental
  • Price
  • IMCR $28.42
  • GEL $13.10
  • Analyst Decision
  • IMCR Buy
  • GEL Buy
  • Analyst Count
  • IMCR 12
  • GEL 3
  • Target Price
  • IMCR $63.00
  • GEL $15.50
  • AVG Volume (30 Days)
  • IMCR 213.2K
  • GEL 677.5K
  • Earning Date
  • IMCR 05-07-2025
  • GEL 05-01-2025
  • Dividend Yield
  • IMCR N/A
  • GEL 5.04%
  • EPS Growth
  • IMCR N/A
  • GEL N/A
  • EPS
  • IMCR N/A
  • GEL N/A
  • Revenue
  • IMCR $310,202,000.00
  • GEL $2,966,216,000.00
  • Revenue This Year
  • IMCR $18.97
  • GEL N/A
  • Revenue Next Year
  • IMCR $8.43
  • GEL $5.29
  • P/E Ratio
  • IMCR N/A
  • GEL N/A
  • Revenue Growth
  • IMCR 24.37
  • GEL N/A
  • 52 Week Low
  • IMCR $27.19
  • GEL $9.86
  • 52 Week High
  • IMCR $66.00
  • GEL $15.17
  • Technical
  • Relative Strength Index (RSI)
  • IMCR 41.60
  • GEL 67.18
  • Support Level
  • IMCR $28.24
  • GEL $12.67
  • Resistance Level
  • IMCR $31.20
  • GEL $13.54
  • Average True Range (ATR)
  • IMCR 1.68
  • GEL 0.49
  • MACD
  • IMCR -0.06
  • GEL 0.04
  • Stochastic Oscillator
  • IMCR 28.94
  • GEL 67.00

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a United States-based limited partnership that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

Share on Social Networks: